Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 4
1(25.0%)
4Total
N/A(3)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07561398Phase 4Recruiting

Comparison of Topical Insulin and Amniotic Membrane Transplant for Persistent Corneal Epithelial Defects

Role: lead

NCT06834906Not ApplicableRecruiting

Usability User Testing of the Easy-EyeFM AI Platform

Role: collaborator

NCT05747417Not ApplicableCompleted

Prismatic Correction for Improving Near Visual Acuity in Patients With Maculopathy

Role: lead

NCT04782635Not ApplicableCompleted

Effect of Artificial Intelligence on Nutritional Status of Children Post Cardiac Surgery

Role: lead

All 4 trials loaded